<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01773382</url>
  </required_header>
  <id_info>
    <org_study_id>PK8197</org_study_id>
    <nct_id>NCT01773382</nct_id>
  </id_info>
  <brief_title>The Effects of Weight Reduction in IgA Nephropathy</brief_title>
  <acronym>WeightPro</acronym>
  <official_title>The Effects of Weight Reduction in Chronic Proteinuric IgA Nephropathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to explore the non-pharmacological treatment of IgA nephropathy by weight
      reduction. The investigators hypothesized that benefits of weight loss may reduce
      proteinuria.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective randomized study in adult IgA nephropathy. The investigators enrolled
      30 patients who have proteinuria exceeds 1 g per day with biopsy proven IgA nephropathy. The
      experimental arm recieves the non-pharmacological treatment, weight reduction protocol. All
      patients in this arm must be reduce their body weight in 3-5 % from baseline as protocol.
      Another arm is control group which recieves standard treatment of IgA nephropathy including
      ACEIs/ARBs for blood pressure control (target &lt; 130/80 mmHg). The primary outcome is
      proteinuria level. The secondary outcome is cytokines and inflammatory markers level
      including interleukin-6, resistin, adiponectin, leptin and monocyte chemoattractant
      protein-1.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">April 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage change of 24-hour proteinuria</measure>
    <time_frame>6 months</time_frame>
    <description>The investigators measure amount of 24-hour proteinuria at randomization peroid ( as baseline), first, third and sixth month. Then, investigators calculate the percentage reduction of proteinuria at different time points.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>plasma concentration of IL-6, adiponectin, resistin, leptin, MCP-1</measure>
    <time_frame>6 months</time_frame>
    <description>The investigators measure amount of plasma concentration of IL-6, adiponectin, resistin, leptin, MCP-1 at randomization peroid ( as baseline) and sixth month. Then, investigators calculate the percentage reduction of these cytokines in 6 months peroid.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Proteinuria</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard treatment of IgA nephropathy including ACEI/ARB for blood pressure control (target BP &lt;130/80 mmHg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>weight reduction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>target weight reduction is 3-5% from baseline</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>weight reduction</intervention_name>
    <description>Set target daily energy requirement by nutritionist (25-30 Kcal/Kg/day minus 500 Kcal)
Advice and encourage patients to do aerobic exercise at least 30 minutes/day for 4-5 days/weeks.
Daily body weight measurement.
Record food diary</description>
    <arm_group_label>weight reduction</arm_group_label>
    <other_name>controlled weight reduction program</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Biopsy-proven IgA nephropathy

          -  body mass index more than 23 Kg/m2

          -  24 hours urine protein more than 1 g

          -  estimated GFR more than 20 ml/min

        Exclusion Criteria:

          -  pregnancy and lactation

          -  rapidly renal function decline

          -  crescent formation in renal biopsy more than 10%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Piyawan Kittiskulnam, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Chulalongkorn University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of medicine, Chulalongkorn university</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Piyawan Kittiskulnam, M.D.</last_name>
      <phone>6622564251</phone>
      <phone_ext>101</phone_ext>
      <email>piyawankitti@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Piyawan Kittiskulnam, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Talerngsak Kanjanabuch, Ass. Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wiwat Chancharoenthana, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2013</study_first_submitted>
  <study_first_submitted_qc>January 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2013</study_first_posted>
  <last_update_submitted>January 18, 2013</last_update_submitted>
  <last_update_submitted_qc>January 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Talerngsak Kanjanabuch</investigator_full_name>
    <investigator_title>Kidney and metabolic research center, Faculty of medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Proteinuria</mesh_term>
    <mesh_term>Glomerulonephritis, IGA</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

